Parkinson Disease [clinicaltrials_resource:729d4c1afb6cdf15d42978a03f41d94b]
Transcranial Magnetic Stimulation for the Treatment of Parkinson's Disease [clinicaltrials:NCT00001665]Intravenous Levodopa for the Diagnosis of Parkinson's Disease [clinicaltrials:NCT00001928]Treatment of Parkinson's Disease With Eliprodil [clinicaltrials:NCT00001929]Treatment of Parkinson's Disease With a Transdermal Skin Patch [clinicaltrials:NCT00001931]Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease [clinicaltrials:NCT00004387]Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients [clinicaltrials:NCT00004451]Study of LY300164 for the Treatment of Parkinson's Disease [clinicaltrials:NCT00004576]Phase II Study of Pallidotomy for Parkinson Disease [clinicaltrials:NCT00004670]Study of Axial Mobility Exercises in Parkinson Disease [clinicaltrials:NCT00004760]Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease [clinicaltrials:NCT00004826]Randomized Study of Fetal Neurotransplantation for the Treatment of Parkinson's Disease [clinicaltrials:NCT00004844]Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease [clinicaltrials:NCT00006488]Transcranial Magnetic Stimulation in Parkinson's Disease [clinicaltrials:NCT00023062]Study of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease [clinicaltrials:NCT00029666]Chinese Exercise Modalities in Parkinson's Disease [clinicaltrials:NCT00029809]Donepezil to Treat Dementia in Parkinson's Disease [clinicaltrials:NCT00030979]The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's Disease [clinicaltrials:NCT00032812]Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease [clinicaltrials:NCT00036205]Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease. [clinicaltrials:NCT00036218]Effects of Talampanel on Patients With Advanced Parkinson's Disease [clinicaltrials:NCT00036296]clinicaltrials:NCT00037830Embryonic Dopamine Cell Implants for Parkinson's Disease [clinicaltrials:NCT00038116]How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance [clinicaltrials:NCT00040196]JP-1730 to Treat Parkinson's Disease [clinicaltrials:NCT00040209]Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease [clinicaltrials:NCT00040404]Molecular Epidemiology of Parkinson's Disease [clinicaltrials:NCT00042107]Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP) [clinicaltrials:NCT00043849]Single Photon Emission Computed Tomography to Study Receptors in Parkinson's Disease [clinicaltrials:NCT00058721]Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease [clinicaltrials:NCT00058838]clinicaltrials:NCT00062738Investigating the Safety of srTMS in the Treatment of Parkinson's Disease [clinicaltrials:NCT00063284]Studying Automatic Movements in Patients With Parkinson's Disease [clinicaltrials:NCT00063661]NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485 [clinicaltrials:NCT00076492]Cell Studies of Parkinson's Disease [clinicaltrials:NCT00076505]Levetiracetam Treatment of L-Dopa Induced Dyskinesias [clinicaltrials:NCT00076674]clinicaltrials:NCT00082342Parkinson's Research: The Organized Genetics Initiative [clinicaltrials:NCT00086073]clinicaltrials:NCT00086190Biological Markers in Parkinson's Disease [clinicaltrials:NCT00088335]Lisuride Patch to Treat Parkinson's Disease [clinicaltrials:NCT00089622]
condition [clinicaltrials_vocabulary:condition]
Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System [clinicaltrials:NCT00001365]Diagnosis and Natural History Study of Patients With Neurological Conditions [clinicaltrials:NCT00001549]Genetic Analysis of Parkinson's Disease [clinicaltrials:NCT00001640]Gene Analysis of Parkinson's Disease [clinicaltrials:NCT00001643]Transcranial Magnetic Stimulation for the Treatment of Parkinson's Disease [clinicaltrials:NCT00001665]Effects of Brain Stimulation on Learning and Reasoning [clinicaltrials:NCT00001776]Intravenous Levodopa for the Diagnosis of Parkinson's Disease [clinicaltrials:NCT00001928]Treatment of Parkinson's Disease With Eliprodil [clinicaltrials:NCT00001929]Treatment of Parkinson's Disease With a Transdermal Skin Patch [clinicaltrials:NCT00001931]Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease [clinicaltrials:NCT00004387]Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients [clinicaltrials:NCT00004451]Study of LY300164 for the Treatment of Parkinson's Disease [clinicaltrials:NCT00004576]Phase II Study of Pallidotomy for Parkinson Disease [clinicaltrials:NCT00004670]Parkinson's Disease Treatment With Coenzyme Q10 [clinicaltrials:NCT00004731]Timing of Levodopa Treatment in Parkinson's Disease [clinicaltrials:NCT00004733]Study of Axial Mobility Exercises in Parkinson Disease [clinicaltrials:NCT00004760]Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease [clinicaltrials:NCT00004826]Randomized Study of Fetal Neurotransplantation for the Treatment of Parkinson's Disease [clinicaltrials:NCT00004844]Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease [clinicaltrials:NCT00006077]KW-6002 to Treat Parkinson's Disease [clinicaltrials:NCT00006337]Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease [clinicaltrials:NCT00006488]EMD 128130 for the Treatment of Parkinson's Disease [clinicaltrials:NCT00009048]Riluzole to Treat Parkinson's Disease [clinicaltrials:NCT00013624]The Association of Neurotoxin Exposure With Parkinson's Disease and Parkinsonism in World War II Veterans and Other Men [clinicaltrials:NCT00018577]Transcranial Magnetic Stimulation in Parkinson's Disease [clinicaltrials:NCT00023062]PET Scanning in Parkinson s Disease [clinicaltrials:NCT00024622]Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's Disease [clinicaltrials:NCT00026598]Magnetic Stimulation for Parkinson Disease [clinicaltrials:NCT00029276]Study of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease [clinicaltrials:NCT00029666]Chinese Exercise Modalities in Parkinson's Disease [clinicaltrials:NCT00029809]Donepezil to Treat Dementia in Parkinson's Disease [clinicaltrials:NCT00030979]The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's Disease [clinicaltrials:NCT00032812]Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease [clinicaltrials:NCT00036205]Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease. [clinicaltrials:NCT00036218]Effects of Talampanel on Patients With Advanced Parkinson's Disease [clinicaltrials:NCT00036296]clinicaltrials:NCT00037830Embryonic Dopamine Cell Implants for Parkinson's Disease [clinicaltrials:NCT00038116]How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance [clinicaltrials:NCT00040196]JP-1730 to Treat Parkinson's Disease [clinicaltrials:NCT00040209]Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease [clinicaltrials:NCT00040404]
condition browse [clinicaltrials_vocabulary:condition-browse]
Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System [clinicaltrials:NCT00001365]Diagnosis and Natural History Study of Patients With Neurological Conditions [clinicaltrials:NCT00001549]Genetic Analysis of Parkinson's Disease [clinicaltrials:NCT00001640]Gene Analysis of Parkinson's Disease [clinicaltrials:NCT00001643]Transcranial Magnetic Stimulation for the Treatment of Parkinson's Disease [clinicaltrials:NCT00001665]Effects of Brain Stimulation on Learning and Reasoning [clinicaltrials:NCT00001776]Intravenous Levodopa for the Diagnosis of Parkinson's Disease [clinicaltrials:NCT00001928]Treatment of Parkinson's Disease With Eliprodil [clinicaltrials:NCT00001929]Treatment of Parkinson's Disease With a Transdermal Skin Patch [clinicaltrials:NCT00001931]Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease [clinicaltrials:NCT00004387]Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients [clinicaltrials:NCT00004451]Study of LY300164 for the Treatment of Parkinson's Disease [clinicaltrials:NCT00004576]Phase II Study of Pallidotomy for Parkinson Disease [clinicaltrials:NCT00004670]Parkinson's Disease Treatment With Coenzyme Q10 [clinicaltrials:NCT00004731]Timing of Levodopa Treatment in Parkinson's Disease [clinicaltrials:NCT00004733]Study of Axial Mobility Exercises in Parkinson Disease [clinicaltrials:NCT00004760]Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease [clinicaltrials:NCT00004826]Randomized Study of Fetal Neurotransplantation for the Treatment of Parkinson's Disease [clinicaltrials:NCT00004844]Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease [clinicaltrials:NCT00006077]KW-6002 to Treat Parkinson's Disease [clinicaltrials:NCT00006337]Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease [clinicaltrials:NCT00006488]EMD 128130 for the Treatment of Parkinson's Disease [clinicaltrials:NCT00009048]Riluzole to Treat Parkinson's Disease [clinicaltrials:NCT00013624]The Association of Neurotoxin Exposure With Parkinson's Disease and Parkinsonism in World War II Veterans and Other Men [clinicaltrials:NCT00018577]Transcranial Magnetic Stimulation in Parkinson's Disease [clinicaltrials:NCT00023062]PET Scanning in Parkinson s Disease [clinicaltrials:NCT00024622]Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's Disease [clinicaltrials:NCT00026598]Magnetic Stimulation for Parkinson Disease [clinicaltrials:NCT00029276]Study of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease [clinicaltrials:NCT00029666]Chinese Exercise Modalities in Parkinson's Disease [clinicaltrials:NCT00029809]Donepezil to Treat Dementia in Parkinson's Disease [clinicaltrials:NCT00030979]The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's Disease [clinicaltrials:NCT00032812]Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease [clinicaltrials:NCT00036205]Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease. [clinicaltrials:NCT00036218]Effects of Talampanel on Patients With Advanced Parkinson's Disease [clinicaltrials:NCT00036296]clinicaltrials:NCT00037830Embryonic Dopamine Cell Implants for Parkinson's Disease [clinicaltrials:NCT00038116]How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance [clinicaltrials:NCT00040196]JP-1730 to Treat Parkinson's Disease [clinicaltrials:NCT00040209]Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease [clinicaltrials:NCT00040404]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Parkinson Disease [clinicaltrials_resource:729d4c1afb6cdf15d42978a03f41d94b]
Bio2RDF identifier
729d4c1afb6cdf15d42978a03f41d94b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:729d4c1afb6cdf15d42978a03f41d94b
identifier
clinicaltrials_resource:729d4c1afb6cdf15d42978a03f41d94b
title
Parkinson Disease
@en
type
label
Parkinson Disease [clinicaltrials_resource:729d4c1afb6cdf15d42978a03f41d94b]
@en
Parkinson Disease